A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-Obstructive Disease

Status:
RECRUITING

Trial end date:
2026-02-27

Target enrollment:

Participant gender:

This study evaluates the safety, tolerability, and activity of inhaled GDC-6988 in participants with muco-obstructive disease.

PHASE1

Genentech, Inc.